Defunct Company
Total Trials
156
As Lead Sponsor
111
As Collaborator
45
Total Enrollment
135,656
NCT00233792
FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 31, 1999
Completion: Mar 31, 2005
NCT00235118
Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)
Completion: Feb 28, 2006
NCT00233818
FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent
Start: Feb 29, 2000
Completion: Jun 30, 2005
NCT00232778
A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)
Start: May 31, 2000
Completion: Jun 30, 2006
NCT00264043
The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.
Phase: Phase 2/3
Completion: Jun 30, 2002
NCT00231270
Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)
Phase: Phase 3
Start: Aug 31, 2000
Completion: Aug 31, 2005
NCT00233805
The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
Phase: Phase 2
Completion: Dec 31, 2007
NCT00232765
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
Start: Feb 28, 2001
Completion: Nov 30, 2008
NCT00232869
A Study of the SMART Stent in the Treatment SFA Disease.
Completion: May 31, 2009
NCT00235144
The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
Start: Mar 31, 2001
Completion: Sep 30, 2008
NCT00381420
The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.
Completion: Jun 30, 2008
NCT00234455
A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.
Start: Jun 30, 2001
Completion: Apr 30, 2007
NCT00233688
Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)
Start: Nov 30, 2001
Completion: Apr 30, 2009
NCT00235157
A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.
Completion: Jul 31, 2005
NCT00231244
Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)
Start: Mar 31, 2002
NCT00264030
Distal Protection Combined With PTCA in AMI Patients
Completion: Aug 31, 2004
NCT00232804
The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent
Phase: Phase 4
Start: Jun 30, 2002
Completion: Feb 29, 2004
NCT00489164
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
Start: Aug 31, 2002
Completion: May 31, 2004
NCT00233766
Evaluation of Two Reduced Sirolimus Doses in Treatment of de Novo Coronary Artery Lesions (REDOX)
Start: Sep 30, 2002
NCT00235066
The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.
Start: Nov 30, 2002
Completion: Apr 30, 2006
NCT00495898
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
Completion: Nov 30, 2009
NCT00232856
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
Start: Dec 31, 2002
Completion: Aug 31, 2006
NCT00258596
Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions
Role: Collaborator
Start: Jan 31, 2003
Completion: Sep 30, 2006
NCT00231257
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
Start: Feb 28, 2003
Completion: Sep 30, 2009
NCT00235170
The Arterial Revascularization Therapies Study Part II.
NCT00233714
Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions
Start: May 31, 2003
NCT00235092
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
Start: Aug 31, 2003
Completion: Mar 31, 2006
NCT00245401
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)
Completion: Dec 31, 2004
NCT00232739
Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
Start: Sep 30, 2003
Completion: Aug 31, 2009
NCT00232752
Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions
NCT00233740
Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)
Completion: May 31, 2005
NCT00232830
The Study to Assess AMI Treated With Balloon Angioplasty.
Start: Oct 31, 2003
NCT00233779
Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION)
NCT00232791
The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.
Start: Jan 31, 2004
NCT00497172
Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial
NCT00749424
The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.
NCT00974181
The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)
Completion: Mar 31, 2010
NCT00231283
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
Start: Apr 30, 2004
NCT00231231
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
Start: Sep 30, 2004
Completion: Nov 30, 2006
NCT00403338
The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)
Phase: N/A
Start: Dec 31, 2004
NCT00489320
An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
Completion: Jul 31, 2006
NCT00232843
The Study to Treat Superficial Femoral Artery Occlusions.
Start: Mar 31, 2005
NCT00714623
The SCRIPPS DES REAL WORLD Registry
Completion: Apr 30, 2012
NCT00257309
Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients
Start: Apr 30, 2005
Completion: Dec 31, 2008
NCT00165035
Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)
Start: May 31, 2005
Completion: Jul 31, 2011
NCT00235131
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent
NCT00378612
ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial
Start: Jun 30, 2005
Completion: Sep 30, 2012
NCT00292305
Nordic Bifurcation Stent Technique Study (BIF II)
Start: Sep 30, 2005
Completion: Dec 31, 2012
NCT00261924
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
Start: Oct 31, 2005
Completion: Jul 31, 2009
NCT00289055
The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions.
Start: Nov 30, 2005
NCT00309595
The Study to Compare SMART Nitinol Stent and Balloon Angioplasty
Start: Dec 31, 2005
NCT00938847
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration
Start: Feb 28, 2006
Completion: Oct 31, 2008
NCT00323895
The Intra-Drug Eluting Stent (DES) Restenosis Study
Start: Mar 31, 2006
Completion: Jan 31, 2010
NCT00438919
A Multi-center Post-Market Surveillance Registry
Start: May 31, 2006
Completion: Dec 31, 2009
NCT00855478
French Post-Marketing Surveillance Survey
NCT00322569
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)
Start: Jul 31, 2006
Completion: May 31, 2012
NCT00403078
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Start: Oct 31, 2006
Completion: Nov 30, 2014
NCT00422565
Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients
NCT00392639
Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)
Start: Nov 30, 2006
NCT00428454
Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions
Start: Jan 31, 2007
Completion: Jun 30, 2015
NCT00924482
Impedance Cardiography: Clinical Evaluation of Endotracheal Cardiac Output Monitor (ECOM)
NCT00345631
Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
Start: Feb 28, 2007
Completion: Sep 30, 2007
NCT00440778
A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI
NCT00440895
A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI
Completion: May 31, 2013
NCT00574691
ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU
Phase: Phase 1
Start: Jun 30, 2007
Completion: Oct 31, 2007
NCT00533156
Plug Arterial Closure System (PACS, 7F)
Start: Jul 31, 2007
Completion: Aug 31, 2007
NCT00753753
VerifyNow French Registry
Start: Feb 29, 2008
NCT00606333
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions
Start: Mar 31, 2008
Completion: Oct 31, 2012
NCT00640770
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease
Completion: Jan 31, 2011
NCT00714883
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
Start: Jun 30, 2008
NCT00715884
Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
Start: Jul 31, 2008
Completion: Sep 30, 2014
NCT00722579
A Study of the Presillion Stent in de Novo Coronary Lesions
NCT00739102
S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease
Start: Aug 31, 2008
Completion: Apr 30, 2013
NCT00827411
Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy
Start: Jan 31, 2009
Completion: Jan 31, 2013
NCT00954707
CYPRESS - CYPHER for Evaluating Sustained Safety
Start: Aug 31, 2009
Completion: Mar 31, 2016
NCT00963690
Evaluation of the CloSys Closure System as an Adjunct to Standard Compression
Completion: May 30, 2013
NCT00977938
The Dual Antiplatelet Therapy Study (DAPT Study)
Start: Oct 31, 2009
Completion: Jun 30, 2014
NCT01106391
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
Start: Mar 31, 2010
Completion: Oct 31, 2016
NCT01106378
Cynergy: the CYPHER-NEVO Registry
Start: Apr 30, 2010
Completion: Dec 31, 2011
NCT01266239
Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (SES) in the Bifurcation Lesion
Start: Jul 31, 2010
Completion: Jul 31, 2015
NCT01202058
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)
Start: Aug 31, 2010
NCT01642563
Italian Platelet Technology Assessment Study
Start: Oct 31, 2010
Completion: Mar 31, 2015
NCT01265849
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Start: Dec 31, 2010
Completion: Dec 4, 2020
NCT01299441
Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
Start: Feb 28, 2011
NCT01355406
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Start: Sep 16, 2011
Completion: Apr 10, 2018
NCT01535716
Effects of a Goal-directed Hemodynamic Therapy Driven by ECOM on Morbidity and Mortality After Cardiac Surgery?
Start: Feb 29, 2012
Completion: Feb 28, 2013
NCT01535612
Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus
Start: Mar 31, 2012
NCT01664078
A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)
Start: Jul 31, 2012
Completion: Oct 10, 2018
NCT01711346
A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells
Start: Oct 31, 2012
NCT01733082
The Mycophenolate Pregnancy Registry
Start: Nov 20, 2012
Completion: Dec 31, 2025
NCT02234830
Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial
Start: Dec 21, 2012
Completion: May 14, 2017
NCT01740531
Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion
Start: Dec 31, 2012
Completion: Dec 31, 2017
NCT01716923
Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia
Start: Apr 30, 2013
Completion: Oct 31, 2014
NCT02462551
Focal Electrically Administered Seizure Therapy for the Treatment of Depression
Start: Sep 30, 2013
Completion: Dec 31, 2016
NCT02115919
Safety Study of Multikine in the Treatment of Perianal Warts
Start: Apr 30, 2014
Completion: Jan 31, 2016
NCT02158078
A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Start: Jun 30, 2014
NCT02060630
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia
Start: Aug 31, 2014
Completion: Mar 1, 2022
NCT02295501
A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease
Start: Dec 31, 2014
Completion: Dec 31, 2020
NCT02310412
A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma
Completion: Sep 30, 2015
NCT02419859
A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus
Start: Feb 28, 2015
Completion: Nov 30, 2015
NCT02477111
European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
Start: Mar 30, 2015
Completion: Dec 9, 2021
NCT02305732
A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components
Start: Mar 31, 2015
Completion: May 31, 2016
NCT03038828
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Start: Apr 30, 2015
Completion: Sep 30, 2018
NCT02381509
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Start: Oct 31, 2015
Completion: Sep 20, 2021
NCT02549222
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Start: Dec 31, 2015
Completion: May 31, 2021
NCT02653443
A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study
NCT02074163
ASIS for Botox in Chronic Migraine
Start: Jan 31, 2016
Completion: Jun 30, 2017
NCT02112097
ASIS for Enbrel in Plaque Psoriasis
NCT02123615
ASIS for GAMMAGARD in Primary Immunodeficiency
Completion: Jun 30, 2016
NCT02853591
Comparison of Pneumoinsufflation Modes and Pressure Settings in Gynecology
Start: Oct 31, 2016
Completion: Dec 31, 2021
NCT03037164
INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections
Start: May 11, 2017
Completion: Jan 30, 2026
NCT03045848
Biofreedom Prospective Multicenter Observational Registry
Start: Jul 5, 2018
Completion: Nov 10, 2020
NCT03128281
Pneumoperitoneum Management With Low vs. Higher Pressure
Start: Jul 31, 2018
Completion: Jul 31, 2022
NCT03216512
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
Start: Sep 21, 2018
Completion: Jan 31, 2019
NCT03459287
Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients
Start: Dec 5, 2018
Completion: Mar 5, 2024
NCT03384407
Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units
Start: Jan 1, 2019
Completion: Dec 31, 2019
NCT03923387
Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device
Start: May 7, 2019
Completion: Sep 1, 2020
NCT03630393
Ultralow Versus Standard Pneumoperitoneum Pressure
Start: May 9, 2019
Completion: Feb 10, 2021
NCT03486054
INTERCEPT Safety Evaluation in Anemic Patients
Start: Jun 30, 2019
Completion: Jun 30, 2020
NCT03965364
China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)
Start: Aug 31, 2019
NCT04022889
In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days
Start: Nov 5, 2019
Completion: Apr 17, 2021
NCT04280029
SELUTION SLR™ 014 In-stent Restenosis
Start: Jul 6, 2020
Completion: Aug 31, 2029
NCT04752670
ConMed Beamer Study
Start: May 27, 2021
Completion: May 1, 2022
NCT04426591
Red Blood Cell Survival in Sickle Cell Disease
Start: Oct 29, 2021
Completion: Apr 30, 2025
NCT05292638
Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
Start: Feb 15, 2022
Completion: Jun 10, 2022
NCT05271487
A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome
Start: Mar 7, 2022
Completion: Mar 1, 2023
NCT05444660
PMCF Study for Peripheral Arteries Below the Knee (BTK)
Start: May 5, 2022
Completion: Nov 2, 2022
NCT05055297
SELUTION4BTK Trial
Start: May 19, 2022
Completion: Jul 30, 2032
NCT05543096
PMCF Study for Cardiology Access Procedures
Start: May 23, 2022
Completion: Sep 7, 2022
NCT05312580
PMCF Study for Peripheral Arteries Above the Knee (ATK)
Start: Jun 1, 2022
Completion: Nov 7, 2022
NCT05382767
Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity
Start: Jun 2, 2022
Completion: Dec 8, 2022
NCT05428930
Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines
Start: Jun 22, 2022
Completion: Oct 25, 2022
NCT05399680
Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
Start: Jun 29, 2022
Completion: Nov 13, 2023
NCT04681638
Plasma Resuscitation Without Lung Injury
Start: Aug 17, 2022
Completion: Sep 29, 2024
NCT05554471
Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression
Start: Aug 30, 2022
Completion: Jul 11, 2023
NCT05132361
SELUTION4SFA Trial
Start: Dec 1, 2022
Completion: Dec 1, 2030
NCT05711524
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
Start: Apr 1, 2023
Completion: Sep 30, 2025
NCT05804656
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
Start: Apr 13, 2023
Completion: Nov 20, 2023
NCT05759039
SHould You TransFer the Tubercle?
Start: Sep 1, 2023
Completion: Sep 1, 2026
NCT05946629
SELUTION 4 De Novo Small Vessel IDE Trial
Start: Oct 20, 2023
Completion: Jun 30, 2031
NCT05959733
Maximal Repair Versus Bridging Reconstruction with BioBrace®
Start: Dec 7, 2023
Completion: Jul 31, 2027
NCT05997381
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
Start: Jan 5, 2024
Completion: Jun 30, 2027
NCT06169800
Biologic Augment of the Medial Patellofemoral Ligament Following Primary Lateral Patellofemoral Dislocation (BioPPD)
Start: Jan 15, 2024
NCT04020224
INTERCEPT Safety Evaluation on Whole Blood
Start: Jan 31, 2024
Completion: Mar 31, 2025
NCT06804070
The Effects of a Botanical Moisturizer and an Unscented Soap on Eczema and Itch
Start: Mar 18, 2024
Completion: Oct 30, 2024
NCT06819709
The Effects of a Botanical Moisturizer, an Oral Supplement, and an Unscented Soap on Eczema and Itch
Start: Apr 15, 2024
Completion: Sep 2, 2024
NCT06697223
A Study to Assess Recovery and Survival of Radiolabeled Apheresis Platelet Components Treated with the INTERCEPT Blood System for Platelets with LED Illuminator.
Start: Jan 31, 2025
NCT07041892
The Effects of an Oral Prebiotic and an Oral Synbiotic Supplement in Combination With a Topical Lotion and Soap On Eczema
Start: Apr 4, 2025
Completion: Jun 30, 2025
NCT06948591
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
Start: Apr 8, 2025
Completion: Jun 30, 2030
NCT07015437
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
Start: Sep 19, 2025
Completion: Oct 15, 2026
NCT07204678
PMCF Study of Precise Pro Rx for Carotid Artery Disease
Start: Sep 30, 2025
NCT07155031
Biotin-Acridine Red Cell Exchange Kinetics
Start: Oct 15, 2025
Completion: Dec 15, 2026
NCT07122518
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
Start: Dec 31, 2025
Completion: Dec 31, 2027
NCT07152379
Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs
Start: Jan 1, 2026
Completion: Jan 1, 2028
NCT07218185
Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage
Start: May 31, 2026
Completion: Aug 31, 2028